Abstract
Hemocyanins are large and versatile glycoproteins performing various immunological and biological functions in many marine invertebrates including arthropods and molluscs. This review discusses the various pharmacological applications of mollusc hemocyanin such as antiviral activity, immunostimulatory and anticancer properties that have been reported in the literature between the years 2000 and 2016. Emphasis is placed on a better mechanistic understanding of hemocyanin as a therapeutic agent. Elucidation of the mechanism of action is essential to improve the clinical efficacy and for a better understanding of some endogenous immunological functions of this complex glycoprotein.
Keywords: Hemocyanin, mollusc, mechanism of action, antiviral activity, immunotherapy, cancer vaccines.
Current Medicinal Chemistry
Title:From Ocean to Bedside: the Therapeutic Potential of Molluscan Hemocyanins
Volume: 25 Issue: 20
Author(s): Negar Talaei Zanjani, Monica Miranda Saksena, Fariba Dehghani*Anthony L. Cunningham *
Affiliation:
- School of Chemical and Biomolecular Engineering, Faculty of Engineering & IT, The University of Sydney, Sydney,Australia
- Centre for Virus Research, Westmead Institute for Medical Research, The University of Sydney, Sydney,Australia
Keywords: Hemocyanin, mollusc, mechanism of action, antiviral activity, immunotherapy, cancer vaccines.
Abstract: Hemocyanins are large and versatile glycoproteins performing various immunological and biological functions in many marine invertebrates including arthropods and molluscs. This review discusses the various pharmacological applications of mollusc hemocyanin such as antiviral activity, immunostimulatory and anticancer properties that have been reported in the literature between the years 2000 and 2016. Emphasis is placed on a better mechanistic understanding of hemocyanin as a therapeutic agent. Elucidation of the mechanism of action is essential to improve the clinical efficacy and for a better understanding of some endogenous immunological functions of this complex glycoprotein.
Export Options
About this article
Cite this article as:
Zanjani Talaei Negar , Saksena Miranda Monica, Dehghani Fariba *, Cunningham L. Anthony *, From Ocean to Bedside: the Therapeutic Potential of Molluscan Hemocyanins, Current Medicinal Chemistry 2018; 25 (20) . https://dx.doi.org/10.2174/0929867324666170502124227
DOI https://dx.doi.org/10.2174/0929867324666170502124227 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Bioactivities of Iridoids
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Hepatic Steatosis and Peroxisomal Fatty Acid Beta-oxidation
Current Drug Metabolism Physiology and Therapeutics of Vascular Endothelial Growth Factor in Tumor Immunosuppression
Current Molecular Medicine Synthesis and Inhibitory Effects of Some Novel 1,3-diarylprop-2-en-1-one Analogues in Foxp3 Expression: A Novel Class of Anti-cancer Candidates
Medicinal Chemistry Ascorbic Acid in Cancer Chemoprevention: Translational Perspectives and Efficacy
Current Drug Targets Therapeutic Applications of Mesenchymal Stem Cells: A Comprehensive Review
Current Stem Cell Research & Therapy Role of Genetic Factors in the Pathogenesis of Radial Deficiencies in Humans
Current Genomics Bioactivity of Chitosan and Its Derivatives
Current Organic Chemistry Disorders of Sex Development: A Review
Current Women`s Health Reviews MicroRNAs Regulate the Epithelial to Mesenchymal Transition (EMT) in Cancer Progression
MicroRNA Preparation and Primary Bioevaluation of 99mTc-labeled-1-thio-β-D-Glucose as Melanoma Targeting Agent
Current Radiopharmaceuticals Epidermal Growth Factor Receptor Inhibitors: A New Prospective in the Treatment of Lung Cancer
Current Medicinal Chemistry - Anti-Cancer Agents Druggability of Mortalin for Cancer and Neuro-Degenerative Disorders
Current Pharmaceutical Design QSAR and the Prediction of T-Cell Epitopes
Current Proteomics Polymeric Radiotracers in Nuclear Imaging
Current Drug Delivery NAD+-Linked 15-Hydroxyprostaglandin Dehydrogenase: Structure and Biological Functions
Current Pharmaceutical Design Toxicity and Relative Biological Effectiveness of Alpha Emitting Radioimmunoconjugates
Current Radiopharmaceuticals Novel Patents and Cancer Therapies for Transforming Growth Factor- Beta and Urokinase Type Plasminogen Activator: Potential Use of Their Interplay in Tumorigenesis
Recent Patents on Anti-Cancer Drug Discovery EphA2-Dependent Molecular Targeting Therapy for Malignant Tumors
Current Cancer Drug Targets Neuronal Nicotinic Receptors as Brain Targets for Pharmacotherapy of Drug Addiction
CNS & Neurological Disorders - Drug Targets